Welcome to our dedicated page for CRH PUBLIC CO SEC filings (Ticker: CRH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on CRH PUBLIC CO's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into CRH PUBLIC CO's regulatory disclosures and financial reporting.
CRH public limited company detailed new financing arrangements connected to its planned acquisition of Arcosa, Inc. CRH America Finance, Inc., as borrower, entered into a three-year $2.5 billion Term Loan Facility, which reduced commitments under the previously arranged Bridge Facility to $3.25 billion from $5.75 billion.
Borrowings under the Term Loan Facility will bear interest at the Secured Overnight Financing Rate plus a ratings-based margin, with a quarterly ticking fee on undrawn amounts that steps from 0% to 30% of the applicable margin over time. At closing of the Arcosa merger, Parent expects to use proceeds from the Bridge Facility, the Term Loan Facility and/or alternative financings, together with cash on hand, to satisfy obligations under the Merger Agreement.
CRH Public Ltd Co filed an initial ownership report for new non-management director Will W Anthony, showing a grant of restricted share units. The award covers 1,404 RSUs, each representing the right to receive one ordinary share, as a pro rata portion of the 2026 director RSU award for service from July 1, 2026 until the 2027 Annual General Meeting. The RSUs are a time-based conditional award under the CRH plc Equity Incentive Plan and are scheduled to vest in May 2027, with dividend equivalents to be applied and reported at vesting.
CRH public limited company has agreed to acquire 100% of Arcosa, Inc. in an all-cash merger. Arcosa stockholders will receive $150.00 per share in cash, valuing the company at an enterprise value of approximately $8.5 billion, which represents an acquisition multiple of 11.5x 2026E Adjusted EBITDA including expected run-rate cost synergies of $175 million by year three. The deal will be funded with available cash and committed debt, including a $5.75 billion bridge loan to help finance the purchase price, debt refinancing and related costs. Closing is targeted for Q1 2027, subject to Arcosa stockholder approval, antitrust and other regulatory clearances, and customary conditions, with significant termination fees payable by either side under specified circumstances. CRH also indicates it does not expect to launch a new share buyback tranche when the current program ends and will reassess repurchases after the transaction.
CRH plc is expanding its Board of Directors from 12 to 13 members and has elected W. Anthony (Tony) Will, effective July 1, 2026, as a non-management director. He will receive board compensation and a pro rata Restricted Stock Unit award under CRH’s standard non-management director program.
CRH states there are no family relationships or related-party transactions requiring disclosure connected to his appointment, and no special arrangements under which he was selected. A press release with his biography was issued on June 16, 2026 and furnished as Exhibit 99.1, noting his prior CEO role at CF Industries and current directorship at Union Pacific.
CRH public limited company reported that holders of its two classes of cumulative preference shares approved plans to cancel these shares at separate scheme meetings. Both meetings were held on May 21, 2026.
For the 7% “A” cumulative preference shares, 496,285 votes were cast in favor of the scheme of arrangement and 30,972 against, with no abstentions. For the 5% cumulative preference shares, 35,782 votes were in favor and 6,543 against, also with no abstentions. Abstentions are not counted in the legal calculation of votes for or against.
CRH PUBLIC LTD CO officer Padraig ORiordain reported an open-market sale of 1,492 Ordinary Shares. The shares were sold on May 15, 2026 at an average price of $104.445 per share. After this transaction, he directly owns 1,205 Ordinary Shares. The footnote notes that the reported price reflects the sale price and that detailed trade breakdowns are available to the SEC on request.
CRH PUBLIC LTD CO director Badar Khan reported routine equity compensation activity. On May 13, 2026, 1,976 restricted share units vested and were exercised into 2,004 Ordinary Shares, including 28 additional shares as dividend equivalents under the company’s equity incentive plan.
To cover related tax liabilities, 962 Ordinary Shares were mandatorily withheld, leaving Khan with 3,542 Ordinary Shares directly held after these transactions. Separately, he received a new time-based conditional award of 1,556 restricted share units, each representing one future Ordinary Share, scheduled to vest in May 2027 with dividend equivalents applying on vesting.
CRH PUBLIC LTD CO director Christina Campbell Verchere reported compensation-related equity transactions involving Ordinary Shares and Restricted Share Units on May 13, 2026. She exercised derivative awards for 2,004 Ordinary Shares at $0.00 per share and received a new grant of 1,556 Restricted Share Units, each representing one Ordinary Share.
A total of 962 Ordinary Shares were disposed of at $108.75 per share to satisfy tax withholding obligations arising from the vesting of a prior time-based RSU award under the CRH plc 2025 Equity Incentive Plan, rather than through an open-market sale. Following these transactions, she directly held 2,042 Ordinary Shares in one line item and 1,556 RSUs in another.
CRH Public Ltd Co officer Padraig O’Riordain reported compensation-related share movements. On May 13, 2026, one-third of a time-based award of 7,464 restricted share units vested, resulting in 2,488 Ordinary Shares being delivered under the equity incentive plan.
To cover withholding tax liabilities from this vesting, 1,317 Ordinary Shares were mandatorily sold at a volume-weighted average price of $110.4137, with sale prices ranging from $109.02 to $111.515. Following these transactions, O’Riordain directly holds 2,697 Ordinary Shares and 10,612 restricted share units.
CRH PUBLIC LTD CO director Caroline Dowling reported equity compensation-related transactions involving Ordinary Shares and Restricted Share Units (RSUs). On May 13, 2026, 1,976 RSUs vested and were exercised into Ordinary Shares under the CRH plc 2025 Equity Incentive Plan, reflecting a time-based award with dividend equivalents. To cover associated tax liabilities, 1,047 Ordinary Shares were automatically withheld, a non-market disposition. On the same date, she also received a new grant of 1,556 RSUs, which is scheduled to vest in May 2027. Following these transactions, she directly holds 3,004 Ordinary Shares and 1,556 RSUs, indicating a net increase in her overall equity exposure to CRH driven by routine compensation events rather than open-market trading.